Isolated peptides to treat alpha-synuclein diseases
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 20, 2009
Grant Date -
Feb 10, 2005
app pub date -
Jul 30, 2004
filing date -
Jul 7, 2000
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to drug screening methods and methods of preventing neural tissue damage caused by α-synuclein aggregation. These methods are especially useful in the design and development of inhibitors of Lewy body diseases and other synucleinopathies, and further useful in the treatment of such neurodegenerative diseases, particularly Parkinson's Disease.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully